| 10.766 |
COMMUNITY FACILITIES LOANS AND GRANTS |
$16.29M |
| 93.310 |
TRANS-NIH RESEARCH SUPPORT |
$11.79M |
| 93.498 |
PROVIDER RELIEF FUND |
$4.01M |
| 93.399 |
CANCER CONTROL |
$2.67M |
| 93.RD |
COVID-19 Community Cohort |
$2.55M |
| 93.350 |
NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES |
$1.11M |
| 93.RD |
CONNECT FOR CANCER PREVENTION STUDY |
$972,523 |
| 94.006 |
AMERICORPS |
$807,289 |
| 93.RD |
VACCINE SAFETY DATALINK INFRASTRUCTURE |
$445,855 |
| 93.859 |
BIOMEDICAL RESEARCH AND RESEARCH TRAINING |
$420,352 |
| 93.788 |
OPIOID STR |
$402,550 |
| 93.RD |
COVID-19 VACCINES IN THE VACCINE SAFTETY DATALINK |
$366,174 |
| 16.575 |
CRIME VICTIM ASSISTANCE |
$362,684 |
| 32.006 |
COVID-19 TELEHEALTH PROGRAM |
$345,061 |
| 93.959 |
BLOCK GRANTS FOR PREVENTION AND TREATMENT OF SUBSTANCE ABUSE |
$219,744 |
| 93.155 |
RURAL HEALTH RESEARCH CENTERS |
$195,677 |
| 93.323 |
EPIDEMIOLOGY AND LABORATORY CAPACITY FOR INFECTIOUS DISEASES (ELC) |
$151,956 |
| 93.RD |
RVTN - SENTINEL RESPIRATORY VIRUS TRANSMISSION NETWORK |
$151,691 |
| 93.866 |
AGING RESEARCH |
$138,570 |
| 93.393 |
CANCER CAUSE AND PREVENTION RESEARCH |
$92,847 |
| 21.027 |
CORONAVIRUS STATE AND LOCAL FISCAL RECOVERY FUNDS |
$87,410 |
| 93.RD |
FLU VACCINE TRIAL |
$87,286 |
| 10.001 |
AGRICULTURAL RESEARCH_BASIC AND APPLIED RESEARCH |
$66,822 |
| 93.396 |
CANCER BIOLOGY RESEARCH |
$59,748 |
| 10.525 |
FARM AND RANCH STRESS ASSISTANCE NETWORK COMPETITIVE GRANTS PROGRAM (B) |
$57,319 |
| 93.395 |
CANCER TREATMENT RESEARCH |
$52,312 |
| 93.RD |
SENTINEL |
$50,705 |
| 93.RD |
CARDIOVASCULAR DISEASES RESEARCH |
$49,688 |
| 93.243 |
SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES_PROJECTS OF REGIONAL AND NATIONAL SIGNIFICANCE |
$48,822 |
| 93.RD |
VACCINE SAFETY DATALINK PROJECT, VSD COVID-19 INFRASTRUCTURE PARTICIPANTING SITE MONITORING FOR VACCINE-ASSOCIATED ENHANCED DISEASES |
$33,654 |
| 93.241 |
STATE RURAL HOSPITAL FLEXIBILITY PROGRAM |
$28,724 |
| 93.898 |
CANCER PREVENTION AND CONTROL PROGRAMS FOR STATE, TERRITORIAL AND TRIBAL ORGANIZATIONS |
$28,346 |
| 93.912 |
RURAL HEALTH CARE SERVICES OUTREACH, RURAL HEALTH NETWORK DEVELOPMENT AND SMALL HEALTH CARE PROVIDER QUALITY IMPROVEMENT |
$28,243 |
| 93.426 |
IMPROVING THE HEALTH OF AMERICANS THROUGH PREVENTION AND MANAGEMENT OF DIABETES AND HEART DISEASE AND STROKE |
$27,044 |
| 93.073 |
BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES - PREVENTION AND SURVEILLANCE |
$26,401 |
| 93.262 |
OCCUPATIONAL SAFETY AND HEALTH PROGRAM |
$26,232 |
| 93.RD |
Optimal Strategies to Estimate the Relative Effectiveness of Influenza |
$25,003 |
| 10.212 |
SMALL BUSINESS INNOVATION RESEARCH |
$21,373 |
| 93.643 |
CHILDREN'S JUSTICE GRANTS TO STATES |
$10,016 |
| 93.435 |
INNOVATIVE STATE AND LOCAL PUBLIC HEALTH STRATEGIES TO PREVENT AND MANAGE DIABETES AND HEART DISEASE AND STROKE- |
$10,000 |
| 93.988 |
COOPERATIVE AGREEMENTS FOR STATE-BASED DIABETES CONTROL PROGRAMS AND EVALUATION OF SURVEILLANCE SYSTEMS |
$9,747 |
| 93.421 |
STRENGTHENING PUBLIC HEALTH SYSTEMS AND SERVICES THROUGH NATIONAL PARTNERSHIPS TO IMPROVE AND PROTECT THE NATION’S HEALTH |
$9,468 |
| 93.307 |
MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH |
$6,451 |
| 93.301 |
SMALL RURAL HOSPITAL IMPROVEMENT GRANT PROGRAM |
$5,950 |
| 93.153 |
COORDINATED SERVICES AND ACCESS TO RESEARCH FOR WOMEN, INFANTS, CHILDREN, AND YOUTH |
$5,282 |
| 93.837 |
CARDIOVASCULAR DISEASES RESEARCH |
$4,465 |
| 10.303 |
INTEGRATED PROGRAMS |
$4,416 |
| 93.279 |
DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS |
$4,325 |
| 93.394 |
CANCER DETECTION AND DIAGNOSIS RESEARCH |
$2,633 |
| 93.575 |
CHILD CARE AND DEVELOPMENT BLOCK GRANT |
$1,326 |
| 93.855 |
ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH |
$1,283 |
| 93.RD |
ALLERGY AND INFECTIOUS DISEASES RESEARCH |
$945 |
| 93.211 |
TELEHEALTH PROGRAMS |
$922 |
| 93.RD |
VACCINE SAFETY DATALINK SHINGRIX PARTICIPATING SITE |
$351 |
| 93.865 |
CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH |
$25 |
| 93.185 |
IMMUNIZATION RESEARCH, DEMONSTRATION, PUBLIC INFORMATION AND EDUCATION_TRAINING AND CLINICAL SKILLS IMPROVEMENT PROJECTS |
$-956 |
| 93.RD |
EVALUATING INFLUENZA AND SARSCO V-2 VACCINE EFFECTIVENESS |
$-5,376 |